Ernesto Giorgio Reggiani

Mobile Systems International provides market research services to businesses. The private company is based in London, UK, and has subsidiaries in the United States. The British company offers interviews with business decision makers, gamers, consumers, and industry employees to help companies raise money, report to shareholders, and plan marketing and competitor strategies. The company uses the ISO classification framework to value brands and ensure that companies are not valued solely on their balance sheet.

Vidus Ltd. provides prepackaged software services. The company provides a secure, scalable, upgradeable, enterprise-class platform and on-demand software delivery, services that can seamlessly connect mobile workers in the field to real-time corporate data. The company is headquartered in Ipswich, United Kingdom.

i2 Ltd. provides investigative analysis and visualization software for law enforcement and commercial organizations. The company was founded in 1990 by Michael Hunter and Timothy Spiers and is headquartered in Cambridge, UK.

Prelude Ventures Ltd. used to provide investment services for startup companies. Its main targets were advanced materials, communications, drug discovery, medical devices and semiconductor sectors. The company was founded in 1984 and was located in Cambridge, UK.

Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom.

Asset Realisation Co. Plc is in Members Voluntary Liquidation and the company's affairs are subsequently being administered by Samantha Keen and Ian Carr of Grant Thornton UK LLP as joint liquidators. The company was previously called Stem Cell Sciences Plc but changed its name after selling its operating assets to Stem Cells, Inc. The company is developing and applying stem cells and stem cell technologies in biopharmaceutical research and cell-based therapies. The company owns a substantial portfolio of patents and patent applications in both adult and embryonic stem cell fields. These include technologies to permit the generation of purified stem cells and their differentiated progeny for use in genetic, pharmacological and toxilogical screens. Moreover, these technologies can be utilized to provide pure populations of appropriate cell types for transplantation therapies. The operations are carried out through its four business units namely SC Proven, SC Licensing, SC Services and SC Therapy. The company operates in the United Kingdom and Australia.

Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom.